All Stories

ADC Therapeutics shutters UK R&D site, culls several preclinical programs and trims workforce by 30%

After dropping its only clinical-stage candidate last month, ADC Therapeutics is shutting down a U.K. R&D site and laying off 30% of its workforce.

Jun 12, 2025 - 20:20
 0
ADC Therapeutics shutters UK R&D site, culls several preclinical programs and trims workforce by 30%
After dropping its only clinical-stage candidate last month, ADC Therapeutics is shutting down a U.K. R&D site and laying off 30% of its workforce.
Read More

Tags:

Previous Article

Biodégradabilité : Syensqo ouvre son nouveau laboratoire de microbiologie à Lyon

Next Article

Exoskeleton maker Wandercraft raises $75M alongside Renault partnership

Related Posts

Transpire follows in Boehringer's footsteps by licensing PDE4 inhibitor for lung disease

Transpire follows in Boehringer's footsteps by licensin...

Jun 3, 2025  0

Medtronic names new head of acute care and monitoring with Flex's Kate Benedict

Medtronic names new head of acute care and monitoring w...

Jun 11, 2025  0

FDA clears its first blood test for diagnosing Alzheimer's disease, with Fujirebio's Lumipulse

FDA clears its first blood test for diagnosing Alzheime...

May 16, 2025  0